Understanding how CRISPR systems protect against viruses and their potential uses
Mechanisms of CRISPR-mediated immunity and applications beyond editing
This study is looking at how CRISPR helps protect against viruses by figuring out how it spots and remembers viral DNA, which could lead to better treatments for infections using this technology.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11003792 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which CRISPR systems provide immunity against viral infections, particularly focusing on how these systems recognize and integrate viral DNA. By employing bioinformatics and experimental approaches, the study aims to uncover the regulatory DNA motifs that control the functioning of CRISPR systems. This could lead to advancements in using CRISPR technology for various applications beyond gene editing, potentially improving treatments for viral infections. Patients may benefit from enhanced therapies that utilize CRISPR for better immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with viral infections or those interested in advanced therapeutic options involving CRISPR technology.
Not a fit: Patients with non-viral infections or those not affected by CRISPR-related conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that enhance the immune system's ability to fight viral infections.
How similar studies have performed: Other research has shown promising results in utilizing CRISPR technology for various applications, indicating a strong potential for success in this area.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Santiago-Frangos, Andrew — University of Pennsylvania
- Study coordinator: Santiago-Frangos, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.